Clinical trial NCT06012422: Sarcopenia Screening in Elderly Individuals
Official title: Sarcopenia Screening in Elderly Individuals Living in Kirikkale Province
Study type: INTERVENTIONAL
Overall status: NOT_YET_RECRUITING
Phase: NA
Conditions: Sarcopenia
Keywords: rehabilitation
physical inactivity
fragility
Lead sponsor: Kırıkkale University
Sponsor class: OTHER
First posted: 2023-08-25
Enrollment: 843
Sex: ALL
Minimum age (years): 65
Standard ages: OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Intervention model description: There is no randomization in our study, all elderly individuals who meet the inclusion and exclusion criteria will be evaluated.
Primary purpose: SCREENING

Brief summary: In this study, it is aimed to evaluate parameters such as sarcopenia screening, muscle mass measurement, loss of strength that may develop due to sarcopenia, loss of balance and related fall, decrease in functionality, fragility and decreased physical activity in individuals aged 65 years and older in Kırıkkale city center.

Detailed description: Although aging occurs in all periods in the human body, physical, mental and physical aging becomes visible as you get older. This situation is caused by physiological aging, environmental factors, existing chronic diseases and related symptoms. Today, increasing life expectancy and aging population must be taken into account. Since the age-related symptoms of elderly individuals are compatible with the consequences of aging, they can be ignored as a natural process, and therefore its progression cannot be prevented. With our project, it is aimed that screening for sarcopenia will be an exemplary study throughout Turkey and this type of screening will be widespread. In addition, it is aimed to divide elderly individuals into groups as presarcopenia, sarcopenia and severe sarcopenia, and to provide necessary guidance, protective and prevention approaches, strengthening and exercise training.

Demographic data of elderly individuals (age, gender, height, weight, BMI (Body mass index will be obtained by dividing body weight (kg), height (m) squared) occupation, etc.), chronic diseases (hypertension, diabetes, chronic obstructive pulmonary disease) (COPD), rheumatic diseases), drugs used, smoking, alcohol habits, and assistive device use, and the 'Clinical Vulnerability Scale' to evaluate the cognitive status of individuals through the 'Mini Nutritional Assessment form (MNA)'. 'Standardized Mini-Mental Test' to assess balance and walking, 'Tinetti balance and walking test' to evaluate balance and walking, 'Falling Risk Self-Assessment Scale' to assess falls, 'Functional Independence and Challenge Scale' to measure functional independence in activities of daily living. 'Short Physical Performance Test' (KFPT), Sarcopenia screening test (SA) to assess physical fitness RC-F), it is planned to use the Physical Activity Scale for the Elderly (PASE) to evaluate the level of physical activity, to use hand dynamometer, to evaluate muscle strength, and to measure the muscle mass of individuals with an inbody bioimpedance device.

Eligibility criteria: Inclusion Criteria:

* Individuals aged 65 and over
* Their willingness to participate in the study
* A score of 24 or higher on the Mini Mental State Test (MMDT)

Exclusion Criteria:

* Individuals under the age of 65
* Individuals who cannot communicate well
* Elderly individuals who cannot walk independently, have any orthopedic or neurological problems
* Individuals who do not want to participate in the study
* Individuals not eligible for bioimpedance analysis (pregnant individuals with pacemakers).

Primary outcomes:
measure: Bioimpedance Analysis
timeFrame: day 1
Secondary outcomes:
measure: Muscle Strength Evaluation
timeFrame: day 1
measure: Short Physical Performance Test
timeFrame: day 1
measure: SARC-F
timeFrame: day 1
measure: Mini Nutritional Assessment
timeFrame: day 1
measure: Physical Activity Scale for the Elderly
timeFrame: day 1
measure: Tinetti balance and walking test
timeFrame: day 1
measure: Fall Risk Self-Assessment Scale
timeFrame: day 1
measure: Anthropometric Measurements
timeFrame: day 1
Other outcomes:
Locations:
Study officials:
References: